| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e31f7c32511408c9e44ab16ef5ddf702 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0012 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16 |
| filingDate |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ff9e2a41e4a5c519ffca25bc3e323d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5a709b96f2da624d8bfd9e10dd8e11e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e668ecb372fb95fdf3899ca74d037bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13736067daa3e0be9c809148c7f7f4de |
| publicationDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1860110-A1 |
| titleOfInvention |
Cyclodextrins functionalised with etodolac as specific site release agents |
| abstract |
β-Cyclodextrin was functionalized with (+/-) etodolac through an ester bond, and the two diastereomers were isolated and characterized as molecules with anti-infiammatory or antitumoral activity. The presence of cyclodextrin ensures the specific delivery to the intestine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2422818-A3 |
| priorityDate |
2006-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |